Adjuvant therapy for gastric carcinoma: closing out the century.

Abstract

Gastric cancer is often advanced and unresectable at diagnosis. Even when a curative resection is possible, the 5-year survival rate for patients with T2 or higher tumors is less than 50%. Survival rates are even lower if lymph node metastases are present at surgery. Many phase III trials of adjuvant therapy have been conducted around the world during the… (More)

Topics

Cite this paper

@article{Yao1999AdjuvantTF, title={Adjuvant therapy for gastric carcinoma: closing out the century.}, author={J. C. Yao and K. Shimada and Jayanna Ajani}, journal={Oncology}, year={1999}, volume={13 11}, pages={1485-94; discussion 1497-502 passim} }